Looks for markers of current or past infection with Hepatitis A, B and C, alongside a liver function panel, in one venous blood test; suited to anyone wanting all three viruses and liver health checked together.
12 biomarkers as listed by Blue Horizon Medicals.
This panel looks for markers of current or past infection across all three of the most commonly tested hepatitis viruses, Hepatitis A, B and C, using antibody and antigen markers such as Core Antibody, Hepatitis B Surface Antibody and Antigen, and Hepatitis C Antibody. It also includes a full liver function test, covering markers such as ALT, ALP, bilirubin, albumin, globulin and total protein, which can show early signs of liver strain alongside the viral results.
With 12 biomarkers in total, this places in the 97th percentile for clinical depth among the immunity and infection tests we track, reflected in a maximum depth score. That breadth comes at a cost: at £173.25, it sits around 35% above the £128.63 median for the eight similarly sized immunity tests we track, which is why value for money scores lower here than on the provider's single-marker hepatitis tests.
Documentation is strong, with a detailed description, the full biomarker list, sample type and turnaround all stated clearly. Collection requires a venous blood sample, since this is not offered as a finger-prick test, taken at a clinic or partner location, or via a nurse home visit, with results reviewed by a doctor within 5 days.
This suits anyone who wants to check all three major hepatitis viruses and get a liver function read-out from a single blood draw, rather than ordering separate Hepatitis A, B and C tests. It is also relevant if you have had a potential exposure through blood, blood products or sexual contact and want a broader check than a single-virus test.
If you only need to check one specific virus, such as past Hepatitis A infection, the provider's standalone Hepatitis A IgG or IgM tests are considerably cheaper at £89.25 each, though you would need to order them separately for the equivalent coverage.
You provide a venous blood sample, since this test is not available as a finger-prick kit; the provider offers collection at a clinic or partner location, or through a nurse home visit. The lab tests for Hepatitis A, B and C antibodies and antigens alongside a liver function panel. Results are reviewed by a doctor, with a turnaround of 5 days.
This venous blood test screens for Hepatitis A, B and C antibodies and antigens alongside a full liver function panel, across 12 biomarkers in total. It costs £173.25, around 35% above the £128.63 median for the eight similarly sized immunity tests we track, reflecting its broader scope. Results are reviewed by a doctor within 5 days, though it is not available as a finger-prick sample.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
12 biomarkers, placing it in the 97th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£173.25 against a median of £128.63 for the 8 similarly sized immunity tests we track (+35%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
